Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Current Opinion in HIV and AIDS|July 27, 2012
Clinical studies with chemokine receptor-5 (CCR5)-inhibitorsChristoph Boesecke, Sarah L PettExpert Review of Anti-Infective Therapy|October 16, 2004
Cytokine therapies in HIV-1 infection: present and futureSarah L Pett, Anthony D KelleherDrugs|June 4, 2010
Role of interleukin-2 in patients with HIV infectionSarah L Pett, Anthony D Kelleher, Sean EmeryHIV Medicine|October 11, 2021
No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adultsJames E Burns, Oliver Stirrup, Laura Waters, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 1, 2013
Skeletal muscle toxicity associated with raltegravir-based combination antiretroviral therapy in HIV-infected adultsFrederick J Lee, Janaki Amin, Mark Bloch, et al.Oxford Open Immunology|February 27, 2023
SARS-CoV-2 immunity and vaccine strategies in people with HIVClaire Mullender, Kelly A S da Costa, Aljawharah Alrubayyi, et al.Sexual Health|January 9, 2017
Managing two decades of visceral leishmaniasis and HIV co-infection: a case report that illustrates the urgent research needs in the fieldMelissa L Kelly, Angie N Pinto, Dan Suan, et al.The Australasian Journal of Dermatology|February 22, 2011
Enfuvirtide injection site reactions: a clinical and histopathological appraisalBrian J Wallace, King-Bing Tan, Sarah L Pett, et al.AIDS Research and Human Retroviruses|June 22, 2010
A novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infectionSarah L Pett, John Zaunders, Michelle Bailey, et al.Pageof 6